Unique substrate specificity of anaplastic lymphoma kinase (ALK): Development of phosphoacceptor peptides for the assay of ALK activity

被引:49
作者
Donella-Deana, A
Marin, O
Cesaro, L
Gunby, RH
Ferrarese, A
Coluccia, AML
Tartari, CJ
Mologni, L
Scapozza, L
Gambacorti-Passerini, C
Pinna, LA
机构
[1] Univ Padua, Dept Biochem, I-35121 Padua, Italy
[2] Venetian Inst Mol Med, I-35129 Padua, Italy
[3] Natl Canc Inst, Dept Expt Oncol, I-20133 Milan, Italy
[4] Univ Geneva, Pharm Sect, Chim Therapeut Lab, CH-1211 Geneva, Switzerland
关键词
D O I
10.1021/bi0472954
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The anaplastic lymphoma kinase (ALK), whose constitutively active fusion proteins are responsible for 5- 10% of non-Hodgkin's lymphomas, shares with the other members of the insulin receptor kinase (IRK) subfamily an activation loop (A-loop) with the triple tyrosine motif Y-x-x-x-Y-Y. However, the amino acid sequence of the ALK A-loop differs significantly from the sequences of both the IRK A-loop and the consensus A-loop for this kinase subfamily. A major difference is the presence of a unique "RAS" triplet between the first and second tyrosines of the ALK A-loop, which in IRK is replaced by "ETD". Here we show that a peptide reproducing the A-loop of ALK is readily phosphorylated by ALK, while a homologous IRK A-loop peptide is not unless its "ETD" triplet is substituted by "RAS". Phosphorylation occurs almost exclusively at the first tyrosine of the Y-x-x-x-Y-Y motif, as judged by Edman analysis of the phosphoradiolabeled product. Consequently, a peptide in which the first tyrosine had been replaced by phenylalanine (FYY) was almost unaffected by ALK. In contrast, a peptide in which the second and third tyrosines had been replaced by phenylalanine (YFF) was phosphorylated more rapidly than the parent peptide (YYY). A number of substitutions in the YFF peptide outlined the importance of Ile and Arg at positions n - I and n + 6 in addition to the central triplet, to ensure efficient phosphorylation by ALK. Such a peculiar substrate specificity allows the specific monitoring of ALK activity in crude extracts of NPM-ALK positive cells, using the YFF peptide, which is only marginally phosphorylated by a number of other tyrosine kinases.
引用
收藏
页码:8533 / 8542
页数:10
相关论文
共 43 条
[1]   Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-γ to mediate its mitogenicity [J].
Bai, RY ;
Dieter, P ;
Peschel, C ;
Morris, SW ;
Duyster, J .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (12) :6951-6961
[2]   Nucleophosmin-anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathway [J].
Bai, RY ;
Tao, OY ;
Miething, C ;
Morris, SW ;
Peschel, C ;
Duyster, J .
BLOOD, 2000, 96 (13) :4319-4327
[3]   Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis [J].
Bischof, D ;
Pulford, K ;
Mason, DY ;
Morris, SW .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (04) :2312-2325
[4]   Oncogenic kinase signalling [J].
Blume-Jensen, P ;
Hunter, T .
NATURE, 2001, 411 (6835) :355-365
[5]   The spleen protein-tyrosine kinase TPK-IIB is highly similar to the catalytic domain of p72(syk) [J].
Brunati, AM ;
James, P ;
Guerra, B ;
Ruzzene, M ;
DonellaDeana, A ;
Pinna, LA .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 240 (02) :400-407
[6]   ISOLATION AND IDENTIFICATION OF 2 PROTOONCOGENE PRODUCTS RELATED TO C-FGR AND FYN IN A TYROSINE-PROTEIN-KINASE FRACTION OF RAT SPLEEN [J].
BRUNATI, AM ;
JAMES, P ;
DONELLADEANA, A ;
MATOSKOVA, B ;
ROBBINS, KC ;
PINNA, LA .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 216 (01) :323-327
[7]   NPM-ALK transgenic mice spontaneously develop T-cell lymphomas, and plasma cell tumors [J].
Chiarle, R ;
Gong, JZ ;
Guasparri, I ;
Pesci, A ;
Cai, J ;
Liu, J ;
Simmons, WJ ;
Dhall, G ;
Howes, J ;
Piva, R ;
Inghirami, G .
BLOOD, 2003, 101 (05) :1919-1927
[8]   ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor [J].
Coffin, CM ;
Patel, A ;
Perkins, S ;
Elenitoba-Johnson, KSJ ;
Perlman, E ;
Griffin, CA .
MODERN PATHOLOGY, 2001, 14 (06) :569-576
[9]   Protein kinases - the major drug targets of the twenty-first century? [J].
Cohen, P .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (04) :309-315
[10]   Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor - A comparative immunohistochemical study [J].
Cook, JR ;
Dehner, LP ;
Collins, MH ;
Ma, ZG ;
Morris, SW ;
Coffin, CM ;
Hill, DA .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (11) :1364-1371